Insider · CIK 0001405279
Frederick W Ahlholm
Files at NERV (Minerva Neurosciences, Inc.). First filing -, latest -.
In brief
Frederick W Ahlholm files SEC Form 4 as CFO at NERV (Minerva Neurosciences, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Frederick W Ahlholm has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 3, 2026 | NERV Minerva Neurosciences, Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +680,000 | $0.00 | $0 | 680,000 | Jun 5, 2026 |
| Dec 22, 2025 | NERV Minerva Neurosciences, Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +500,000 | $0.00 | $0 | 500,000 | Dec 23, 2025 |
| Dec 5, 2024 | NERV Minerva Neurosciences, Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +47,500 | $0.00 | $0 | 47,500 | Dec 6, 2024 |
Questions about Frederick W Ahlholm
Answered from the filings on this page, as of the latest one.
Is Frederick W Ahlholm buying or selling?
Frederick W Ahlholm has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Frederick W Ahlholm's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Frederick W Ahlholm has 0.
Where does Frederick W Ahlholm file Form 4?
Frederick W Ahlholm has filed Form 4 at NERV (Minerva Neurosciences, Inc.) as SVP, CFO and Secretary. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.